Welcome to our dedicated page for Oscar Health news (Ticker: $OSCR), a resource for investors and traders seeking the latest updates and insights on Oscar Health stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Oscar Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Oscar Health's position in the market.
Oscar Health, a healthcare technology company, will participate in the BofA Securities 2024 Global Health Care Conference. Chief Financial Officer, Scott Blackley, will present a business update on May 15, 2024. Interested parties can listen to the webcast on Oscar's investor relations website.
Oscar Health, Inc. announced its financial results for the first quarter of 2024, reporting total revenue of $2.1 billion, a 46% increase year-over-year. The company achieved positive net income of $177.4 million, with diluted earnings per share of $0.62. Key metrics like Medical Loss Ratio and SG&A Expense Ratio showed significant improvements. Adjusted EBITDA improved by $168.2 million year-over-year. The company reaffirmed its full-year 2024 outlook across all metrics.